Longeveron Announces Pricing of $5.25 Million Public Offering
April 08, 2024 14:15 ET
|
Longeveron
Longeveron prices $5.15 million public offering with certain board member and insider participation.
Global Immunoassay for Neurological Biomarkers Market to 2030: Increasing Prevalence of Neurological Diseases Fuels the Sector
June 05, 2023 05:08 ET
|
Research and Markets
Dublin, June 05, 2023 (GLOBE NEWSWIRE) -- The "Immunoassay for Neurological Biomarkers Market Size, Share & Trends Analysis Report By Product, By Disease (Alzheimer's Disease, Parkinson's...
MHRA Grants ADvantage Therapeutics Innovative Licensing and Access Pathway (ILAP) Designation for Novel Lead Product AD04™ for Phase 2b Trial in Alzheimer’s Disease
April 05, 2023 08:35 ET
|
Advantage Therapeutics Inc.
MIAMI, April 05, 2023 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc. (“ADvantage” or “the Company”), which is developing therapies to treat neurodegenerative conditions with a central focus on...
Global Alzheimers Disease Diagnostics and Therapeutics Market Size to grow USD 21704.4 Million by 2030 | CAGR of 5.5%
October 24, 2022 05:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, Oct. 24, 2022 (GLOBE NEWSWIRE) -- According to a research report published by Spherical Insights & Consulting, the Global Alzheimers Disease Diagnostics and Therapeutics...
Todos Medical Announces Legacy Convertible Note Extension, Lock-Up Agreements, and New Debt Financing
February 25, 2020 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos and Amarantus JV Announces Full Enrollment for Clinical Trial of LymPro Alzheimer’s Blood Test Relationship with Amyloid PET
November 14, 2019 11:02 ET
|
Todos Medical Ltd.
Topline results expected before the end of Q1/2020 REHOVOT, Israel and NEW YORK, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company...
Todos Medical Signs Binding Term Sheet with HWH World for Network Marketing of Blood Tests for the Early Detection of Breast Cancer
September 13, 2019 07:30 ET
|
Todos Medical Ltd.
REHOVOT, Israel and SINGAPORE, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the...
Todos Medical Appoints Dr. Jorge Leon as Medical Advisor
August 06, 2019 07:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos Medical Announces Positive Alzheimer's Biomarker Clinical Data from LymPro vs. Amyloid PET Interim Analysis
July 15, 2019 07:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, July 15, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostic company focused on the development of blood tests for the early...
Todos Medical to Appoint Dr. Paula Trzepacz As Chief Medical Officer And Files New Patent Application
July 12, 2019 11:05 ET
|
Todos Medical Ltd.
Joint venture Breakthrough Diagnostics files new patent application covering Alzheimer’s blood diagnostic LymPro Test clinical correlation with amyloid PET imagingPreliminary Data on LymPro vs....